Patients with HCC have a worse prognosis and a more aggressive tumor when FBXW7 expression is lost (Table 4) (Wang et al., 2015; Zhou et al., 2012; Feng et al., 2022). This evidence concerns the gene FBXW7 and hepatocellular carcinoma.